Minerva Neurosciences (NERV) Change in Acquisitions & Divestments (2015 - 2020)

Minerva Neurosciences has reported Change in Acquisitions & Divestments for 5 years, with the latest figure at $3.0 million in Q3 2020.

• For the quarter ending Q3 2020, Change in Acquisitions & Divestments fell 91.63% year-over-year to $3.0 million; the trailing twelve-month figure through Dec 2020 stood at $28.4 million (down 62.22% YoY), and the FY2020 full-year result was $28.4 million, down 62.22% from the prior year.
• Change in Acquisitions & Divestments for Q3 2020 stood at $3.0 million, down from $4.5 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $39.2 million in Q1 2018, with the low at $1.4 million in Q2 2016.
• Historically, Change in Acquisitions & Divestments has averaged $16.5 million across 4 years, with a median of $9.2 million in 2019.
• The largest YoY upside for Change in Acquisitions & Divestments was 132.22% in 2020 against a maximum downside of 91.63% in 2020.
• Minerva Neurosciences' Change in Acquisitions & Divestments stood at $8.4 million in 2016, then sank by 36.72% to $5.3 million in 2018, then soared by 76.11% to $9.3 million in 2019, then sank by 67.86% to $3.0 million in 2020.
• The last three Change in Acquisitions & Divestments figures came in at $3.0 million (Q3 2020), $4.5 million (Q2 2020), and $20.9 million (Q1 2020), per Business Quant data.